A Promising Breakthrough for Triple‐Negative Breast Cancer by Targeting the AKT and EZH2

Saved in:
Bibliographic Details
Published inMedComm (2020) Vol. 6; no. 8; pp. e70318 - n/a
Main Authors Liu, Zhuoyun, Li, Yirong, Long, Xinghua
Format Journal Article
LanguageEnglish
Published China John Wiley & Sons, Inc 01.08.2025
John Wiley and Sons Inc
Wiley
Subjects
Highlight
Online AccessGet full text

Cover

More Information
Bibliography:Funding
This work was supported by grants from the National Natural Science Foundation of China (81272372) and by the Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund (PTXM2022017).
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ObjectType-News-1
Funding: This work was supported by grants from the National Natural Science Foundation of China (81272372) and by the Zhongnan Hospital of Wuhan University Science, Technology and Innovation Seed Fund (PTXM2022017).
ISSN:2688-2663
2688-2663
DOI:10.1002/mco2.70318